Skip to main content
. 2019 Sep 30;9(10):75. doi: 10.1038/s41408-019-0237-1

Fig. 4.

Fig. 4

Hazard of developing second primary malignancies (SPMs) in patients with a diagnosis of chronic lymphocytic leukemia (CLL) in a multivariate model utilizing patient gender, age category at diagnosis, race, year of diagnosis, and whether or not the patients received chemotherapy